Pharma EPC & Construction Contractors in India

India's pharmaceutical construction pipeline is one of the most active in the industrial sector. Projects India currently tracks 1,426 upcoming drugs and pharmaceuticals projects across the country, of which 1,140 are verified, with a combined recorded project cost of approximately Rs 92,190 crore. The promoters behind this pipeline range from listed API manufacturers and multinational formulation companies to state-backed bulk drug infrastructure bodies — each representing a distinct contracting and procurement opportunity for pharma EPC contractors and construction firms.

Most Active Promoters in the Pharma Project Pipeline

The table below lists the promoters with the highest number of projects in our database. These are the organisations actively commissioning plant construction, expansion and infrastructure work across India's pharmaceutical sector.

As the chart below shows, these promoters represent a broad cross-section — multinational formulation companies, listed Indian API manufacturers, biologics specialists and smaller private firms — all of which procure construction, engineering and equipment services through distinct channels.

Largest Individual Pharmaceutical Plant Projects in India

For pharmaceutical contractors, the size and stage of individual projects determine when to engage and what scope to bid. Our records show the following as the largest upcoming projects currently in the pipeline:

Projects already at Construction Started — such as the Andhra Pradesh Bulk Drug Infrastructure Corporation plant in Visakhapatnam and the Torrent Pharmaceuticals facility in Gandhinagar — are in active procurement and works engagement. Projects at Approvals Received or Under Approvals are the ones worth approaching now, before tendering begins.

Where the Demand Is: States, Cities and Project Stages

As the chart below shows, Gujarat leads all states in project count, followed by Telangana, Andhra Pradesh and Karnataka — together accounting for the majority of tracked activity.

Gujarat's dominance is partly structural: the Ankleshwar and Bharuch chemical and pharma clusters have drawn sustained investment over many years, and our database continues to add new projects there. Two projects added to our database in the last 90 days — a bulk drugs intermediates expansion by Valeshvar Biotech and a new bulk drugs unit by VB Genetics — are both located in Ankleshwar, confirming that the cluster remains active for smaller-scale plant construction as well. For a closer look at Gujarat-specific leads, see our article on upcoming pharma projects in Gujarat.

Telangana and Andhra Pradesh together host 389 projects in our records. The Hyderabad pharma cluster, Genome Valley and the dedicated bulk drug parks at Visakhapatnam and Kurnool drive this concentration. Karnataka — with 184 projects — is notable for biologics and high-value API manufacturing, anchored by Bengaluru's biotech ecosystem.

As the chart below shows, a significant share of all projects across the full pipeline (including completed and cancelled) sits at the Under Approvals stage, meaning regulatory and environmental clearances are being sought. This is immediately followed by Construction Started projects, which represent immediate on-site work. The Approvals Received cohort — projects that have cleared the regulatory hurdle but not yet begun construction — is where forward-looking contractors should concentrate business development effort.

Our database added 19 new pharma projects in the last 90 days, up from 15 in the prior 90-day period. New additions include mid-scale API projects in Tamil Nadu, Karnataka and Goa, as well as an Rs 195 crore API expansion by Chromo Laboratories in Sangareddy, Telangana. The full list of drugs and pharmaceuticals projects is updated continuously.

How to Approach These Companies

The right timing and the right contact vary considerably by project stage, plant type and promoter profile.

• Planning and Under Approvals: At this stage the promoter is still structuring the project. Contact is typically with corporate engineering, projects or capital expenditure teams. EPC contractors can position themselves early, submit credentials and participate in vendor pre-qualification. Equipment suppliers can begin technical conversations that later feed into detailed design.
• Approvals Received: Regulatory clearances are in hand and the promoter is selecting project management consultants and preparing bid packages. This is the critical window for EPC firms to get on shortlists and for specialist subcontractors — HVAC, cleanroom, instrumentation, fire protection — to register with likely main contractors.
• Construction Started: Main civil and structural contracts are usually placed. Subcontract packages for mechanical, electrical, plumbing and process equipment installation are often still being awarded. Equipment suppliers for long-lead items such as reactors, distillation columns and utility systems should already be engaged before this stage.
• Hold: Projects marked Hold — including the Granules India API plant in East Godavari at Rs 2,000 crore and the P&G unit in Sanand, Ahmedabad at Rs 2,000 crore — are worth monitoring but not pursuing for immediate work. Revisit them when the status changes.

Pharma plant procurement differs from general industrial construction. Promoters often split contracts between a process technology licensor, a project management consultant, a civil and structural EPC contractor, and specialist vendors for cleanrooms, process equipment and utilities. Knowing which split a specific promoter uses — and who their PMC is — determines the correct point of entry. The VendorConnect contractor and supplier directory is a useful resource for identifying which firms are already active with a given promoter.

For government-backed projects such as the Andhra Pradesh Bulk Drug Infrastructure Corporation plant in Visakhapatnam, procurement follows public tender processes. Monitoring live government tenders in this sector is essential for contractors targeting state-promoted pharma parks and bulk drug clusters.

What This Means for Pharma Suppliers and Contractors

The scale and geographic spread of India's pharmaceutical construction pipeline creates differentiated opportunities depending on a firm's capability profile.

• Large EPC contractors capable of handling Rs 500 crore-plus integrated projects should focus on the Approvals Received and Construction Started cohort, particularly in Andhra Pradesh's bulk drug park projects and Karnataka's biologics facilities.
• Mid-tier civil and structural contractors will find the bulk of volume in Gujarat and Telangana, where a high density of smaller API and formulation plant projects creates consistent demand for standard industrial construction without the complexity of sterile or containment-grade facilities.
• Cleanroom and process equipment specialists should track the vaccines and biologics projects — Serum Institute in Pune, HLL Biotech in Chennai and Biocon Biologics in Bengaluru — as these require the most specialist scope.
• Equipment and material suppliers — reactors, piping, HVAC, instrumentation, utility systems — should note that the 362 projects currently at Construction Started represent active procurement. The 639 projects under approvals and 137 projects with approvals received collectively represent the forward pipeline where relationships should be built now.
• Consultants and PMCs should target promoters at the Planning and Under Approvals stages, before engineering contracts are awarded. Divi's Laboratories, with 8 projects and Rs 2,800 crore in recorded spend, and Biocon Biologics, with 6 projects and Rs 2,264 crore, represent the most sustained consulting demand in the current pipeline.

The pipeline's breadth — from a Rs 7 crore bulk drugs unit in Ankleshwar to a Rs 12,000 crore pharma park in Lalitpur — means that almost every tier of contractor and supplier can find relevant work. The differentiator is knowing which projects are moving, when, and who is making procurement decisions. For firms selling into the chemical and process industry more broadly, our guide on chemical companies and plants in India provides additional context on overlapping client sets.

To track all 1,426 upcoming projects in this sector, including verified project contacts and tender alerts, visit the Projects India intelligence database or request a free sample project report to see the level of detail available before subscribing.